164 related articles for article (PubMed ID: 37716525)
21. Bradykinin mediated gastrointestinal edema as a cause of abdominal attacks in patients with hereditary angioedema due to C1-inhibitor deficiency.
Obtulowicz P; Piotrowicz-Wojcik K; Dyga W; Stobiecki M; Popiela T; Obtulowicz K
J Physiol Pharmacol; 2022 Apr; 73(2):. PubMed ID: 36193964
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor Deficiency.
Kalmi G; Nguyen Y; Amarger S; Aubineau M; Bibes B; Blanchard-Delaunay C; Boccon-Gibod I; Bouillet L; Coppo P; Dalmas MC; Debord-Peguet S; Defendi F; Demoreuil C; Du-Thanh A; Gayet S; Hadjadj J; Jeandel PY; Launay D; Ly KH; Avoy CM; Niault M; Ollivier Y; Pelletier F; Porneuf M; Roos-Weil D; Fain O; Gobert D
J Allergy Clin Immunol Pract; 2024 Jan; 12(1):212-222. PubMed ID: 37844846
[TBL] [Abstract][Full Text] [Related]
23. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
[TBL] [Abstract][Full Text] [Related]
24. Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations and genetic factors modifying the clinical phenotype.
Grivčeva-Panovska V; Košnik M; Korošec P; Andrejević S; Karadža-Lapić L; Rijavec M
Ann Med; 2018 May; 50(3):269-276. PubMed ID: 29513108
[TBL] [Abstract][Full Text] [Related]
25. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks.
Craig TJ; Bewtra AK; Hurewitz D; Levy R; Janss G; Jacobson KW; Packer F; Bernstein JA; Rojavin MA; Machnig T; Keinecke HO; Wasserman RL
Allergy Asthma Proc; 2012; 33(4):354-61. PubMed ID: 22856636
[TBL] [Abstract][Full Text] [Related]
26. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal experience with treatment of acquired angioedema using tranexamic acid.
Kesh S; Singh U; Bernstein JA
Allergy Asthma Proc; 2022 Sep; 43(5):413-418. PubMed ID: 36065111
[No Abstract] [Full Text] [Related]
28. Hereditary and acquired angioedema.
Patel G; Pongracic JA
Allergy Asthma Proc; 2019 Nov; 40(6):441-445. PubMed ID: 31690390
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.
Aygören-Pürsün E; Magerl M; Maetzel A; Maurer M
Orphanet J Rare Dis; 2018 May; 13(1):73. PubMed ID: 29728119
[TBL] [Abstract][Full Text] [Related]
30. Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study.
Grumach AS; Henriques MT; Bardou MLD; Pontarolli DA; Botha J; Correa M;
An Bras Dermatol; 2022; 97(4):448-457. PubMed ID: 35654647
[TBL] [Abstract][Full Text] [Related]
31. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
Jacobs J; Neeno T
Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
[TBL] [Abstract][Full Text] [Related]
32. Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship.
Castelli R; Zanichelli A; Cicardi M; Cugno M
Crit Rev Oncol Hematol; 2013 Sep; 87(3):323-32. PubMed ID: 23490322
[TBL] [Abstract][Full Text] [Related]
33. Hereditary angioedema with normal C1-inhibitor: Clinical and genetic characterization of 15 Portuguese unrelated families.
Dias de Castro E; Pinhal AL; Bragança M; Parente Freixo J; Martinho A
Ann Allergy Asthma Immunol; 2024 Jun; 132(6):730-736. PubMed ID: 38342132
[TBL] [Abstract][Full Text] [Related]
34. Hereditary angioedema in children and adolescents - A consensus update on therapeutic strategies for German-speaking countries.
Wahn V; Aberer W; Aygören-Pürsün E; Bork K; Eberl W; Faßhauer M; Krüger R; Magerl M; Martinez-Saguer I; Späth P; Staubach-Renz P; Weber-Chrysochoou C
Pediatr Allergy Immunol; 2020 Nov; 31(8):974-989. PubMed ID: 32524650
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children.
Reshef A; Grivcheva-Panovska V; Kessel A; Kivity S; Klimaszewska-Rembiasz M; Moldovan D; Farkas H; Gutova V; Fritz S; Relan A; Giannetti B; Magerl M
Pediatr Allergy Immunol; 2019 Aug; 30(5):562-568. PubMed ID: 30993784
[TBL] [Abstract][Full Text] [Related]
36. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and therapeutic management of hereditary angioedema due to C1-inhibitor deficiency: the Italian experience.
Cancian M;
Curr Opin Allergy Clin Immunol; 2015 Aug; 15(4):383-91. PubMed ID: 26106828
[TBL] [Abstract][Full Text] [Related]
38. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation.
Cugno M; Castelli R; Cicardi M
Autoimmun Rev; 2008 Dec; 8(2):156-9. PubMed ID: 19014872
[TBL] [Abstract][Full Text] [Related]
39. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.
Bork K; Machnig T; Wulff K; Witzke G; Prusty S; Hardt J
Orphanet J Rare Dis; 2020 Oct; 15(1):289. PubMed ID: 33059692
[TBL] [Abstract][Full Text] [Related]
40. Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review.
Shi Y; Wang C
Clin Immunol; 2021 Sep; 230():108819. PubMed ID: 34358691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]